Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2Dermatologic 2Sarcoma 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 13Nasopharyngeal Carcinoma 13Carcinoma, Non-Small-Cell Lung 6Triple Negative Breast Neoplasms 5Stomach Neoplasms 4Pancreatic Neoplasms 4Nasopharyngeal Neoplasms 4Melanoma 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Mesothelioma 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Bile Duct Neoplasms 2Anus Neoplasms 2Adenocarcinoma Of Esophagus 2

Interventions

pembrolizumab 12Nivolumab 4tislelizumab 2spartalizumab 2belinostat 2atezolizumab 2Ipilimumab 2venetoclax 1tocilizumab 1talazoparib 1rovalpituzumab tesirine 1obinutuzumab 1naptumomab estafenatox 1milademetan 1epacadostat 1durvalumab 1budigalimab 1Tablets 1Sorafenib 1Sirolimus 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1LY2940680 1Immunotherapy 1Fluorouracil 1Drug Therapy 1Doxepin 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma × spartalizumab × Head & Neck × Clear all
NCT04802876 2025-03-21

ACROPOLI

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting
184 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Uveal Melanoma, Anus Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Neoplasms, Unknown Primary, Sarcoma, Thyroid Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04672434 2024-12-09

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Symphogen A/S

Phase 1 Completed
48 enrolled
GastrointestinalGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms, Esophageal Neoplasms, Mesothelioma, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡